These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11466718)

  • 21. [Successful prevention of Pneumocystis carinii infection with 1,920 mg of trimethoprim-sulfamethoxazole daily in patients with malignant hematopoietic diseases].
    Lemez P; Rysková P; Votava V; Suchmová M; Jirásek A; Rubík I
    Vnitr Lek; 1995 Oct; 41(10):688-91. PubMed ID: 8578700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pneumocystis carinii pneumonia prophylaxis and early clinical manifestations of severe perinatal human immunodeficiency virus type 1 infection. Northern California Pediatric HIV Consortium.
    Maldonado YA; Araneta RG; Hersh AL
    Pediatr Infect Dis J; 1998 May; 17(5):398-402. PubMed ID: 9613653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined trimethoprim and caspofungin treatment for severe Pneumocystis jiroveci pneumonia in a five year old boy with acute lymphoblastic leukemia.
    Beltz K; Kramm CM; Laws HJ; Schroten H; Wessalowski R; Göbel U
    Klin Padiatr; 2006; 218(3):177-9. PubMed ID: 16688676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients.
    Lindemulder S; Albano E
    Pediatrics; 2007 Jul; 120(1):e47-51. PubMed ID: 17606548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.
    Aricò M; Valsecchi MG; Rizzari C; Barisone E; Biondi A; Casale F; Locatelli F; Lo Nigro L; Luciani M; Messina C; Micalizzi C; Parasole R; Pession A; Santoro N; Testi AM; Silvestri D; Basso G; Masera G; Conter V
    J Clin Oncol; 2008 Jan; 26(2):283-9. PubMed ID: 18182669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
    Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
    Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
    J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole.
    Park JW; Curtis JR; Kim MJ; Lee H; Song YW; Lee EB
    Arthritis Res Ther; 2019 Sep; 21(1):207. PubMed ID: 31521185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pneumocystis carinii pneumonia in infants after heart transplantation.
    Janner D; Bork J; Baum M; Chinnock R
    J Heart Lung Transplant; 1996 Aug; 15(8):758-63. PubMed ID: 8878758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Dapsone Versus Trimethoprim/Sulfamethoxazol for Pneumocystis Jiroveci Prophylaxis in Children With Acute Lymphoblastic Leukemia With a Background of Ethnic Neutropenia.
    Nazir HF; Elshinawy M; AlRawas A; Khater D; Zadjaly S; Wali Y
    J Pediatr Hematol Oncol; 2017 Apr; 39(3):203-208. PubMed ID: 28234744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
    Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
    Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral absorption of trimethoprim-sulfamethoxazole in patients with AIDS.
    Klepser ME; Zhu Z; Nicolau DP; Banevicius MA; Belliveau PP; Ross JW; Broisman L; Quintiliani R; Nightingale CH
    Pharmacotherapy; 1996; 16(4):656-62. PubMed ID: 8840373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
    Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group.
    Ek T; Mellander L; Andersson B; Abrahamsson J
    Pediatr Blood Cancer; 2005 May; 44(5):461-8. PubMed ID: 15558707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study.
    Yamashita K; Shimomura Y; Ikesue H; Muroi N; Yoshimoto A; Hashida T
    BMC Infect Dis; 2021 Jul; 21(1):664. PubMed ID: 34238239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
    Schrauder A; Reiter A; Gadner H; Niethammer D; Klingebiel T; Kremens B; Peters C; Ebell W; Zimmermann M; Niggli F; Ludwig WD; Riehm H; Welte K; Schrappe M
    J Clin Oncol; 2006 Dec; 24(36):5742-9. PubMed ID: 17179108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New aspects of epidemiology and treatment of Pneumocystis carinii infection].
    Powierska-Czarny J; Gospodarek E; Czerwionka-Szaflarska M
    Pol Merkur Lekarski; 2004 Nov; 17(101):534-7. PubMed ID: 15754652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
    Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
    Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
    El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R
    Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.